Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
about
Emerging pharmacotherapy for cancer patients with cognitive dysfunctionClinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsCognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients.Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study.Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients.
P2860
Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
@en
Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
@nl
type
label
Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
@en
Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
@nl
prefLabel
Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
@en
Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
@nl
P2093
P2860
P356
P1476
Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
@en
P2093
Govardhanan Nagaiah
Jame Abraham
Michael Batalo
P2860
P304
P356
10.1586/ERA.11.112
P577
2011-08-01T00:00:00Z